INTRODUCTION
============

Carcinoma of the breast, the third most common cancer worldwide, accounts for the highest morbidity and mortality \[[@B1]\]. It is also the second leading cause of cancer death in women, after lung cancer \[[@B2]\]. The etiology of breast cancer is multifactorial. Hormonal, genetic, and environmental factors are implicated in the pathogenesis of breast cancer \[[@B3]\]. Furthermore, reactive oxygen species (ROS), such as superoxide anions and hydrogen peroxide-induced lipid peroxidation, play a major role in malignant transformation \[[@B4]\] and tumor cell proliferation and invasion \[[@B5], [@B6], [@B7]\]. It has been hypothesized that the production of ROS in combination with a decrease in the activity of antioxidant enzymes may be characteristic of tumor cells \[[@B8], [@B9]\].

Superoxide dismutase (SOD) is a family of ubiquitous antioxidant metalloproteinases that catalyze the conversion of superoxide anion radicals to hydrogen peroxide and molecular oxygen \[[@B10]\]. Three different isoforms of SOD (cytosolic Cu/Zn SOD or SOD1, mitochondrial Mn-SOD or SOD2, and extracellular SOD or SOD3) exist within this family. Among these three, manganese superoxide dismutase (Mn-SOD) which is localized at the mitochondrial matrix \[[@B11], [@B12], [@B13]\] has shown the ability to reverse malignant phenotype in a variety of human tumor cells that are low or absent in Mn-SOD expression. It has been hypothesized that the Mn-SOD gene is a tumor suppressor \[[@B14], [@B15]\]. Mn-SOD activity has been reported to be decreased in many transformed cell lines suggesting that an altered Mn-SOD gene may play an important role in the development of cancer \[[@B16], [@B17], [@B18], [@B19]\]. The purpose of the present study was to investigate whether a differential expression of Mn-SOD exists between nontumorigenic human mammary epithelial cell lines (MCF-12A and MCF-12F), nonaggressive human breast cancer cell lines (MCF-7) and aggressive cancerous human mammary epithelial cell lines (BT-549 and 11-9-14).

MATERIALS AND METHODS
=====================

Maintenance of human mammary epithelial cell lines
--------------------------------------------------

Five cell lines representing nontumorigenic (MCF-12A and MCF-12F), nonaggressive cancerous (MCF-7), and aggressive cancerous (11-9-14 and BT-549) human mammary epithelial cells were used in this study. All cell lines except 11-9-14 were obtained from ATCC, Va. 11-9-14 cell line was obtained from the Tissue Procurement Facility, Meharry Medical College, Nashville, Tenn. It was originated from the human breast epithelial cell line BT-549 at ATCC and transfected with galectin-3, a *β*-galactoside binding protein (a cell adhesion molecule). The cells were cultured in DMEM/F-12, supplemented with 100 *μ*g/mL penicillin-streptomycin, 2.5 *μ*g/mL fungizone, 20 ng/mL epidermal growth factor, 98 ng/mL cholera toxin, 10% heat-inactivated fetal bovine serum, 2 mM glutamine, and nonessential amino acids. The cultures were maintained at 37^°^C in a humidified atmosphere of 5% CO~2~ and 95% air. All cell culture supplies were purchased from Sigma, Mo.

Assay of SOD activity
---------------------

SOD activity was measured using alkaline dimethyl sulfoxide as superoxide anion generating system as follows. Samples to be assayed (200 *μ*L) were added to 1 mL of 0.20 M potassium phosphate buffer (pH 8.6) containing 10^−4^ M EDTA and 2 × 10^−5^ M cytochrome C. Tubes were kept in an ice bath for 20 minutes. Then, 0.5 mL alkaline DMSO (DMSO containing 1% water and 5 mM NaOH) was added with stirring. After the addition of alkaline DMSO, the final pH of the solution was usually between 9.5 and 9.6. Absorbance of reduced cytochrome C was determined at 550 nm against samples prepared under similar conditions except that DMSO did not contain NaOH. Mn-SOD activity was determined after incubating the cell lysates with 50 mM NaCN because NaCN inhibits the activity of cytosolic Cu-Zn SOD. The final concentration of NaCN in the assay mixture was 5 mM. A unit of enzymatic activity is the amount of enzyme, which causes 50% inhibition of alkaline DMSO-mediated cytochrome c reduction \[[@B20]\].

![Reverse transcriptase-polymerase chain reaction. The gel picture showing differential RT-PCR product. Lane 1 : 5 *μ*g RNA from MCF-12A in RT-PCR; lane 2 : 5 *μ*g RNA from MCF-12F in RT-PCR; lane 3 : 5 *μ*g RNA from MCF-7 in RT-PCR; lane 4 : 5 *μ*g RNA from BT-549 in RT-PCR; lane 5 : 5 *μ*g RNA from 11-9-14 in RT-PCR; lane 6 : 1 kb plus marker.](40101.fig.001){#F1}

![Slot blot hybridization. Increasing amounts of RNA (0, 1, 2, and 4 *μ*g) were taken from MCF-12A, MCF-12F, MCF-7, BT-549, and 11-9-14 breast epithelial cells and hybridized with probe.](40101.fig.002){#F2}

![Alignment of nucleotide sequence of MCF-12A Mn-SOD gene with that of human GenBank (M36693) sequence.](40101.fig.003){#F3}

![Alignment of peptide sequence of MCF-12A Mn-SOD gene with that of human GenBank (M36693) sequence.](40101.fig.004){#F4}

###### 

Activity of SOD in different cell lines (values are mean ± SEM, $n = 5$). \*Values in cancer cell lines (MCF-7, BT-549, 11-9-14) are significantly different from those in normal cell lines (MCF-12A and MCF-12F), $P < .05$.

  ----------- -------------------------------------- -----------------------------------
  Cell line   Total SOD activity (unit/mg protein)   Mn-SOD activity (unit/mg protein)
                                                     
  MCF-12A     17.77 ± 1.563                          3.04 ± 0.35
  MCF-12F     21.72 ± 1.508                          2.42 ± 0.12
  MCF-7       42.76 ± 5.717\*                        16.38 ± 1.13\*
  BT-549      28.47 ± 1.215\*                        7.83 ± 0.47\*
  11-9-14     29.49 ± 0.858\*                        10.69 ± 0.29\*
  ----------- -------------------------------------- -----------------------------------

###### 

Band intensities (IDV values) of slot blot for normal and cancer cell lines at different RNA concentrations. (Values are mean ± SEM, $n = 5$). Values in cancer cell lines (MCF-7, BT-549, and 11-9-14) are significantly different from those in normal cell lines (MCF-12A and MCF-12F), $P < .05$.

  ------------------ -------------- ------------- -------------- -------------- --------------
  RNA conc. (*μ*g)   IDV values                                                 
                                                                                
  MCF-12A            MCF-12F        MCF-7         BT-549         11-9-14        
                                                                                
  0                  0              0             0              0              0
  1                  0.95 ± 0.003   1.53 ± 0.03   4.49 ± 0.002   1.97 ± 0.002   1.91 ± 0.001
  2                  1.37 ± 0.05    2.11 ± 0.04   4.71 ± 0.1     2.84 ± 0.06    3.25 ± 0.04
  4                  1.76 ± 0.08    2.44 ± 0.14   5.37 ± 0.49    3.24 ± 0.11    3.04 ± 0.61
  ------------------ -------------- ------------- -------------- -------------- --------------

###### 

Comparison of nucleotide sequence of RT-PCR products of Mn-SOD gene between different human breast cell lines.

  ----------- --------------------------- ------------------------------ ---------------------------------------------
  Cell line   Number of bases sequenced   Aligned with M36693 (Mn-SOD)   Change against M36693
                                                                         
  MCF-12A     652                         98--736                        ^*g*^130~*c*~, ^*c*^139~*t*~, ^*c*^339~*t*~
  MCF-12F     637                         136--732                       ^*c*^141~*t*~, ^*c*^339~*t*~, ^*t*^625~*c*~
  MCF-7       631                         106--736                       ^*c*^339~*t*~
  11-9-14     640                         107--746                       ^*c*^339~*t*~
  BT-549      627                         107--733                       ^*c*^141~*t*~
  ----------- --------------------------- ------------------------------ ---------------------------------------------

###### 

Comparison of amino acid (AA) sequence of Mn-SOD gene between different human breast cell lines.

  ----------- ------------------------ ------------------------------ ------------------------------------------
  Cell line   Number of AA Sequenced   Aligned with M36693 (Mn-SOD)   Mutation against M36693
                                                                      
  MCF-12A     217                      2--214                         ^*Q*^12~*H*~, ^*A*^16~*V*~, ^*T*^82~*I*~
  MCF-12F     212                      15--213                        ^*A*^16~*V*~, ^*T*^82~*I*~
  MCF-7       210                      5--214                         ^*T*^82~*I*~
  BT-549      209                      5--213                         ^*A*^16~*V*~
  11-9-14     213                      5--217                         ^*T*^82~*I*~
  ----------- ------------------------ ------------------------------ ------------------------------------------

Isolation of RNA
----------------

RNA was isolated from 10^6^ cells using Trizol (Invitrogen, Md). Cells were first washed with sterile PBS three times and resuspended in 1 mL Trizol and sonicated in a Branson sonifier cell disrupter. The mixture was kept in room temperature for 5 minutes. Then 200 *μ*L chloroform was added and the mixture was vigorously shaken. The phases were separated by centrifuging at 12 000 rpm for 15 minutes at 4^°^C. The RNA was then precipitated from the aqueous phase with isopropanol (25^°^C). The pellet was washed with ample amounts of sterile, 70% ethanol (25^°^C). The concentration and the purity of the RNA were analyzed in a UV spectrophotometer.

Slot blot hybridization
-----------------------

Slot blot hybridization was performed using increasing amounts of RNA from all samples. The reverse primer, 5′GTATCTTTCAGTTACATTCTCCCA-3′, for SOD and forward primer, 5′GTGGAGTCTACTGGCGTCTTC-3′, for GAPDH were digoxigenin-labeled for slot blot hybridization using the Terminal DIG labeling kit (Roche Biochemicals, Ind). Different amounts of RNA (0, 1, 2, and 4 *μ*g) from all cells were loaded onto a positively charged nylon membrane (MSI, Ga) using a Turboblotter (BioRad, Calif). The samples were then linked to the membrane using a UV crosslinker (Stratagene, Calif). A nonradioactive detection method using digoxigenin (Roche Biochemicals, Ind) was used to detect any hybridization. The membranes were washed under high-stringent conditions with 0.1 × SSC and 0.1% SDS at 600^°^C for 1 hour before being exposed to the film. The labeled reverse primer was used as the probe and the hybridization was performed following manufacturer\'s instructions. The band intensities (IDV values) were quantitated using the alpha imager (Alpha Innotech, Calif).

Reverse transcriptase-polymerase chain reaction
-----------------------------------------------

RT-PCR of both SOD and GAPDH was performed using 5 *μ*g RNA from each sample, using the One-Step RT-PCR kit (Invitrogen, Md). The primers were synthesized to amplify approximately 200 amino acids in the carboxyl end of the protein and based on the sequences from the GenBank Accession No. M36693. The primer sequences were 5′-TTGAGCCGGGCAGTGTGCGGCACC-3′ (forward) and 5′-GTATCTTTCAGTTACATTCTCCCA-3′ (reverse) for SOD, and 5′GTGGAGTCTACTGGCGTCTTC-3′ (forward) and 5′ CATGCCAGTGAGCTTCCCGTT-3′ (reverse) for GAPDH. RT-PCR was performed in a thermal cycler (Biometra, Tgradient) as follows: 1 cycle for 30 minutes at 45^°^C, 1 cycle for 2 minutes at 94^°^C, 39 cycles for 1 minute at 94^°^C, 1 minute at 50^°^C, 2 minutes at 72^°^C and 1 cycle for 10 minutes at 72^°^C. The RT-PCR products were electrophoresed on a 1% agarose gel, purified using QIAquick PCR purification kit (Qiagen, Calif), and sequenced using BigDye terminators kit (Applied Biosystems, Calif). The sequences were analyzed using Applied Biosystems automated sequencer (ABI 3700 model).

### Statistical analysis

Differences between tumorigenic and nontumorigenic cells were assessed by using ANOVA, and the significance level was set at $P \leq .05$.

RESULTS
=======

Activity of SOD
---------------

Total as well as Mn-SOD activity was varied between cell lines ([Table 1](#T1){ref-type="table"}). The order of activity was MCF-7 (nonaggressive) \> BT-549 and 11-9-14 (aggressive) \> MCF-12A and MCF-12F (nontumorigenic).

Expression of Mn-SOD gene
-------------------------

An RT-PCR yielded products of approximately 0.6 kb for SOD and 0.4 kb for GAPDH in all cell lines. The results showed the differential expression of Mn-SOD gene between nontumorigenic, nonaggressive, and aggressive breast cancer cell lines (BT-549 and 11-9-14) ([Figure 1](#F1){ref-type="fig"}).

A slot blot hybridization ([Figure 2](#F2){ref-type="fig"}) was done with increasing amounts of RNA from nontumorigenic (MCF-12A and MCF-12F), nonaggressive cancerous (MCF-7), and aggressive cancerous (BT-549 and 11-9-14) cell lines to confirm their differential expression of Mn-SOD RNA. The housekeeping gene, *GAPDH*, was used as a positive control. No change in the expression of *GAPDH* was observed with increasing concentration of RNA. The quantitative analysis of the RNA levels shown in [Figure 2](#F2){ref-type="fig"} has been normalized with the RNA level of *GAPDH* gene ([Table 2](#T2){ref-type="table"}) which indicates that the band intensities are different between these cell lines. Highest expression was observed in MCF-7 in comparison with others. Expression was lowest in MCF-12A.

Sequencing of RT-PCR products of Mn-SOD gene
--------------------------------------------

The RT-PCR products from MCF-12A, MCF-12F, MCF-7, BT-549, and 11-9-14 were sequenced and each nucleotide sequence was compared with that of the human Mn-SOD gene as reported in NCBI data base (M36693). We have shown here the alignment of the nucleotide sequence of one representative human breast cell line (MCF-12A) with that of the human Mn-SOD from GenBank (Accession No. M36693) ([Figure 3](#F3){ref-type="fig"}).

With our primers, we could sequence 627 to 652 nucleotides depending on the cell lines ([Table 3](#T3){ref-type="table"}). This sequence exactly aligns to a segment (98--746) of the human Mn-SOD cDNA (976 bp, GenBank Accession No. M36693). In MCF-12A and MCF-12F, we found three base changes in the nucleotide level ([Table 4](#T4){ref-type="table"}). One of these was common in both (^*c*^339~*t*~). The two other changes were different between MCF-12A (^*g*^130~*c*~ and ^*c*^139~*t*~) and MCF-12F (^*c*^141~*t*~ and ^*t*^625~*c*~). When the sequences of MCF-7, BT-549, and 11-9-14 were compared with that of M36693, we found only one substitution in each of these cell lines ([Table 3](#T3){ref-type="table"}). In both MCF-7 and 11-9-14 cell lines, this change was from *c* to *t* (^*c*^339~*t*~) as observed in both MCF-12A and MCF-12F. However, in BT-549, it was from *c* to *t* at 141 (^*c*^141~*t*~).

The nucleotide sequence was translated using human codon usage to give a peptide sequence of 209--217 amino acids ([Table 4](#T4){ref-type="table"}). This sequence exactly corresponds to a segment (2--217) of the Mn-SOD peptide sequence of M36693 (GenBank). For MCF-12A, three amino acid changes were found (^*Q*^12~*H*~, ^*A*^16~*V*~, ^*T*^82~*I*~). Two changes were observed for MCF-12F cell line (^*A*^16~*V*~, ^*T*^82~*I*~). But in other cell lines, only one amino acid substitution (^*T*^82~*I*~ in MCF-7 and 11-9-14, and ^*A*^16~*V*~ in BT-549) was found. The alignment of the peptide sequence of one representative human breast cell line (MCF-12A) with that of the human Mn-SOD from the GenBank (M36693) is shown in [Figure 4](#F4){ref-type="fig"}.

DISCUSSION
==========

Mn-SOD plays a key role in protecting cells against oxidative damage and regulating cellular concentration of $\text{O}_{\text{2}}^{\cdot}$, which is a highly reactive oxidant and an unwanted product of cellular metabolism \[[@B21]\]. Many different types of tumors have been demonstrated to have low Mn-SOD activity \[[@B22]\]. Overexpression of Mn-SOD suppresses the tumorigenicity of human melanoma cells, breast cancer cells, and glioma cells, suggesting that Mn-SOD is a tumor suppressor gene in a wide variety of cancers \[[@B15], [@B23], [@B24]\].

Several reports have however shown that despite generally low levels of Mn-SOD in the center of solid tumor nests, there appeared to be very intense Mn-SOD staining in a few tumor cells located at the leading edge or outside layers of tumors adjacent to benign epithelium in breast and prostate tumors \[[@B25], [@B26]\]. In addition, Mn-SOD expression is increased in metastatic gastric cancer \[[@B27]\]. Lam et al \[[@B28]\] demonstrated that overexpression of Mn-SOD by adenovirus gene transfer in hamster squamous carcinoma cells stimulated tumor cell invasive capacity and this elevation was abolished by adenovirus catalase suggesting the involvement of ROS and particularly by hydrogen peroxide in the process of tumor invasion. Reconstitution of Mn-SOD in tumor cells induces cell resistance to the cytotoxic effects of TNF-*α*, ionizing, and hyperthermia \[[@B29], [@B30], [@B31]\], suggesting that Mn-SOD functions not only as a tumor suppressor but also as a mediator in signaling cell resistance to ROS-induced cytotoxicity \[[@B32]\].

In our study, we find high activity of Mn-SOD in certain breast cancer cell lines especially in MCF-7 cell line ([Table 1](#T1){ref-type="table"}). We speculate that this elevation of Mn-SOD in cancerous breast tissues without a corresponding increase in the activity of catalase and/or glutathione peroxidase would lead to the accumulation of peroxides and oxidative stress and will enhance the progression of cancer. Siemankowski et al \[[@B31]\] also showed a similar kind of activity (∼ 40 U SOD/mg protein) in MCF-7 cell line. Mn-SOD may play a dual role in relation to exposure to ROS. Human cancer has frequently decreased Mn-SOD levels. However, although it is clearly an important scavenger of ROS, the production of H~2~O~2~ by Mn-SOD in specific circumstances may lead to potentially carcinogenic effects, especially if some individuals have a decreased capacity to remove H~2~O~2~ by glutathione peroxidase or catalase. Alternatively, better scavenging capacity may decrease the ability to undergo normal cellular protective mechanisms such as apoptosis; therefore, oxidative stresses would have a greater likelihood of nuclear DNA mutation \[[@B33], [@B34]\]. According to our results (Tables [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}), a G- to C- substitution in 130 positions in MCF-12A (nontumorigenic) was found that changes the amino acid codon at 12 positions in the peptide from *Q* to *H*. But this change was not observed in MCF-7, BT-549, and 11-9-14 cell lines. Rosenblum et al \[[@B35]\] suggest that the alteration may affect the cellular allocation of the enzyme and transport of Mn-SOD into the mitochondrion where it would be biologically available. They further suggest that inefficient targeting of Mn-SOD could leave mitochondria without their full defense against superoxide radicals, which could lead to protein oxidation as well as mitochondrial DNA mutations. Overexpression of Mn-SOD perhaps causes (a) a decrease in the malignant phenotypes of various types of cancer including breast cancer \[[@B15], [@B23]\], (b) an increase in the resistance for cytotoxicity from tumor necrosis factor *α* in breast cancer \[[@B30], [@B36]\], (c) an increase in apoptosis \[[@B37]\], and (d) an improvement in apoptosis after hydrogen peroxide challenge \[[@B37]\]. It is also possible that mitochondrial Mn-SOD could impact on oxidative damage in nuclear DNA, which would be one plausible mechanism for increased risk from a genetic polymorphism in Mn-SOD, although the effects on the mitochondrion alone could be sufficient for its impact on carcinogenesis. Thus, there are a number of ways that changes in the cellular distribution of Mn-SOD might affect breast cancer risk. It should further be noted that this is the first study on the nucleotide and amino acid sequence of Mn-SOD gene in breast epithelial cell lines. This information will be useful in future design of experiments involving Mn-SOD gene in breast epithelial cell lines. Now in our laboratory, we are trying to sequence the whole Mn-SOD cDNA as well as the expression of Mn-SOD mRNA by northern blot analysis.
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